PKD2 and cancer: We recently reported that pharmacological inhibition of HSP90 by PU-H71 was not only associated with augmented cell death and decreased cancer cell proliferation but also lead to destabilization and subsequent proteasomal degradation of protein kinase D2 (PKD2)10.